Interferon Alfa and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer

NCT00002847 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

14

Enrollment

OTHER

Sponsor class

Conditions

Kidney Cancer

Interventions

BIOLOGICAL: aldesleukin
BIOLOGICAL: recombinant interferon alfa
PROCEDURE: conventional surgery

Sponsor

Blumenthal Cancer Center at Carolinas Medical Center